These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17722195)

  • 21. Seamless phase II/III designs.
    Stallard N; Todd S
    Stat Methods Med Res; 2011 Dec; 20(6):623-34. PubMed ID: 20724313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal response-adaptive randomized designs for multi-armed survival trials.
    Sverdlov O; Tymofyeyev Y; Wong WK
    Stat Med; 2011 Oct; 30(24):2890-910. PubMed ID: 21823146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of current guidelines on the care of postherpetic neuralgia.
    Argoff CE
    Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flexible design of two-stage adaptive procedures for phase III clinical trials.
    Koyama T
    Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covariate-adjusted response-adaptive designs for binary response.
    Rosenberger WF; Vidyashankar AN; Agarwal DK
    J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group-sequential methods for adaptive seamless phase II/III clinical trials.
    Stallard N
    J Biopharm Stat; 2011 Jul; 21(4):787-801. PubMed ID: 21516569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal adaptive design in clinical drug development: a simulation example.
    Maloney A; Karlsson MO; Simonsson US
    J Clin Pharmacol; 2007 Oct; 47(10):1231-43. PubMed ID: 17906158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.
    Jenkins M; Stone A; Jennison C
    Pharm Stat; 2011; 10(4):347-56. PubMed ID: 22328327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several.
    Kelly PJ; Stallard N; Todd S
    J Biopharm Stat; 2005; 15(4):641-58. PubMed ID: 16022169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia.
    Jensen MP; Chiang YK; Wu J
    Clin J Pain; 2009 May; 25(4):286-92. PubMed ID: 19590476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of clinical efficacy of amitriptyline and pregabalin in postherpetic neuralgia.
    Achar A; Chakraborty PP; Bisai S; Biswas A; Guharay T
    Acta Dermatovenerol Croat; 2012; 20(2):89-94. PubMed ID: 22726281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pregabalin in the treatment of neuropathic pain].
    Biegstraaten M; van Schaik IN
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1561-5. PubMed ID: 17715763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
    Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postherpetic neuralgia: treatment strategies for pain control.
    Davis TL
    Adv NPs PAs; 2012 Sep; 3(9):29-31. PubMed ID: 23002661
    [No Abstract]   [Full Text] [Related]  

  • 40. Seamless Phase II/III combination study through response adaptive randomization.
    Wang L; Cui L
    J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.